Vagus Nerve Stimulation Helps Children With Drug-Resistant Epilepsy
This study looked at how effective vagus nerve stimulation (VNS) is for children with drug-resistant epilepsy (DRE), which means their seizures do not respond well to medications.
This hub covers epilepsy devices and neuromodulation like VNS, RNS, and DBS, which are treatments that can reduce seizures when meds arenβt enough. Plain-language research summaries plus real-life pros/cons.
Some are used more often in adults, but pediatric use depends on the device, the case, and specialist guidance.
Often gradually. Improvement can build over months as settings are optimized.
Sometimes medication can be reduced, but many people still use meds alongside a device.
Sometimes yes, with device-specific rules. Always check the exact device guidelines first.
This study looked at how effective vagus nerve stimulation (VNS) is for children with drug-resistant epilepsy (DRE), which means their seizures do not respond well to medications.
This study looked at how epilepsy caused by cavernous malformations in the brain is diagnosed and treated in Kazakhstan.
Researchers studied the use of two types of brain monitoringβscalp EEG (scEEG) and stereo EEG (SEEG)βin patients with drug-resistant epilepsy.
Researchers studied 231 children who experienced febrile seizures, which are seizures triggered by fever, to see if they could predict who might develop epilepsy or a specific type of epilepsy called genetic epilepsy with febrile seizures plus (GEFS+).
This study looked at how pediatric epilepsy centers in the United States make decisions about surgery for children with Lennox-Gastaut Syndrome (LGS), a severe type of epilepsy.
Researchers studied infantile epilepsy spasms syndrome (IESS), a serious condition that affects about 3 in 10,000 newborns in the U.S.
Researchers studied the effects of valproate, a medication used to treat epilepsy and bipolar disorder, on infertility in men.
Researchers studied the effectiveness of five newer anti-seizure medications (ASMs) in treating Lennox-Gastaut syndrome (LGS), a severe form of epilepsy that begins in childhood and is often resistant to treatment.
This study looked at the healthcare use and costs for people with drug-resistant epilepsy (DRE) who were enrolled in Medicaid and received a neurostimulator implant.